+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Citeline - Market Research Reports

Citeline's analysis, insight and consultancy services span drug, device, company, clinical trial and market intelligence. All services are delivered by an authoritative team of industry experts in key markets around the globe.

Bone Grafts and Substitutes - Product Thumbnail Image

Bone Grafts and Substitutes

  • Newsletter
  • July 2024
  • 75 Pages
  • Global
Drug Delivery: Injection Devices - Product Thumbnail Image

Drug Delivery: Injection Devices

  • Newsletter
  • July 2024
  • 58 Pages
  • Global
Melanoma KOL Interview - US #2 - Product Thumbnail Image

Melanoma KOL Interview - US #2

  • Newsletter
  • July 2024
  • 12 Pages
  • United States
Acute Myeloid Leukemia (AML) KOL Interview - US, South - Product Thumbnail Image

Acute Myeloid Leukemia (AML) KOL Interview - US, South

  • Newsletter
  • July 2024
  • 16 Pages
  • United States
Pulmonary Hypertension KOL Interview - US #1 - Product Thumbnail Image

Pulmonary Hypertension KOL Interview - US #1

  • Newsletter
  • July 2024
  • 13 Pages
  • United States
Drug Delivery: Infusion Devices - Product Thumbnail Image

Drug Delivery: Infusion Devices

  • Newsletter
  • July 2024
  • 78 Pages
  • Global
Colorectal Cancer KOL Interview - US, Northeast - Product Thumbnail Image

Colorectal Cancer KOL Interview - US, Northeast

  • Newsletter
  • July 2024
  • 14 Pages
  • United States
Pulmonary Hypertension KOL Interview - US #2 - Product Thumbnail Image

Pulmonary Hypertension KOL Interview - US #2

  • Newsletter
  • July 2024
  • 11 Pages
  • United States
Interventional Neurology: Mechanical Thrombectomy Devices - Product Thumbnail Image

Interventional Neurology: Mechanical Thrombectomy Devices

  • Newsletter
  • July 2024
  • 76 Pages
  • Global
Molecular Diagnostics - Product Thumbnail Image

Molecular Diagnostics

  • Newsletter
  • July 2024
  • 100 Pages
  • Global
CMS Actively Looking For New Reimbursement Pathway For Innovative Devices - Product Thumbnail Image

CMS Actively Looking For New Reimbursement Pathway For Innovative Devices

  • Newsletter
  • July 2024
  • 3 Pages
  • Global
From
Kratom Industry Offers Own Standards As Another Firm Warned About FDA Rules - Product Thumbnail Image

Kratom Industry Offers Own Standards As Another Firm Warned About FDA Rules

  • Newsletter
  • July 2024
  • 3 Pages
  • Global
From
The Case For CAR-T Grows As Responses Hold Up Longer Term - Product Thumbnail Image

The Case For CAR-T Grows As Responses Hold Up Longer Term

  • Newsletter
  • July 2024
  • 6 Pages
  • Global
From
Strategy At Novartis: Culture Change As The 'How' Behind The 'What' - Product Thumbnail Image

Strategy At Novartis: Culture Change As The 'How' Behind The 'What'

  • Newsletter
  • July 2024
  • 6 Pages
  • Global
From
116th Congress Could Test Cosmetic Industry's Commitment To Reg Reform, Preemption Viability - Product Thumbnail Image

116th Congress Could Test Cosmetic Industry's Commitment To Reg Reform, Preemption Viability

  • Newsletter
  • July 2024
  • 3 Pages
  • Global
From
GSK And Pfizer Start Consumer JV For Different Reasons, Aim For Similar Goals - Product Thumbnail Image

GSK And Pfizer Start Consumer JV For Different Reasons, Aim For Similar Goals

  • Newsletter
  • July 2024
  • 4 Pages
  • Global
From
Real-World Evidence: US FDA's Prucalopride Review Shows Datasets' Utility And Limitations - Product Thumbnail Image

Real-World Evidence: US FDA's Prucalopride Review Shows Datasets' Utility And Limitations

  • Newsletter
  • July 2024
  • 4 Pages
  • United States
From
Part B Payment Model Indexing Commercial Discounts Proposed By Genentech - Product Thumbnail Image

Part B Payment Model Indexing Commercial Discounts Proposed By Genentech

  • Newsletter
  • July 2024
  • 3 Pages
  • Global
From
Schleifer, Yancopoulos And The $36 Billion Friendship - Product Thumbnail Image

Schleifer, Yancopoulos And The $36 Billion Friendship

  • Newsletter
  • July 2024
  • 4 Pages
  • Global
From
Neuroscience Is The Next Oncology: Why Biogen Is Doubling Down - Product Thumbnail Image

Neuroscience Is The Next Oncology: Why Biogen Is Doubling Down

  • Newsletter
  • July 2024
  • 5 Pages
  • Global
From
Loading Indicator